Filing Details

Accession Number:
0001209191-23-021947
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-31 19:02:07
Reporting Period:
2023-03-29
Accepted Time:
2023-03-31 19:02:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1863127 Tyra Biosciences Inc. TYRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711463 Todd Harris C/O Tyra Biosciences, Inc.
2656 State Street
Carlsbad CA 92008
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-29 1,420 $2.25 1,702,696 No 4 M Direct
Common Stock Disposition 2023-03-29 1,420 $16.18 1,701,276 No 4 S Direct
Common Stock Acquisiton 2023-03-30 2,407 $2.25 1,703,683 No 4 M Direct
Common Stock Disposition 2023-03-30 2,407 $16.02 1,701,276 No 4 S Direct
Common Stock Acquisiton 2023-03-31 500 $2.25 1,701,776 No 4 M Direct
Common Stock Disposition 2023-03-31 500 $16.05 1,701,276 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-03-29 1,420 $0.00 1,420 $2.25
Common Stock Stock Option (Right to Buy) Disposition 2023-03-30 2,407 $0.00 2,407 $2.25
Common Stock Stock Option (Right to Buy) Disposition 2023-03-31 500 $0.00 500 $2.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
402,444 2031-03-09 No 4 M Direct
400,037 2031-03-09 No 4 M Direct
399,537 2031-03-09 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
  2. 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.